NCT06351137

Brief Summary

Prehospital treatment of acute traumatic pain is common in military practice. Analgesics are usually administered intravenously (IV). Research from the civil prehospital environment shows that obtaining IV access can be difficult and time consuming, delaying onset of treatment. The challenges for obtaining IV access in the military prehospital setting are even bigger, for example in combat environments. However, this has not been assessed. Current guidelines also offer alternative routes of administration for analgesics, for example intranasal (IN) administration. IN administration is a fast, easy and effective route of administration. This study determines whether IN administration of analgesia is faster and leads to increased healthcare provider satisfaction compared to IV administration in patients with acute traumatic pain in a simulated military prehospital environment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 8, 2024

Completed
5 days until next milestone

Study Start

First participant enrolled

March 13, 2024

Completed
26 days until next milestone

First Posted

Study publicly available on registry

April 8, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2024

Completed
Last Updated

January 29, 2025

Status Verified

January 1, 2025

Enrollment Period

6 months

First QC Date

March 8, 2024

Last Update Submit

January 28, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time required for administration of analgesic (minutes)

    Time interval starts when healthcare provider grabs the first required item (e.g. tourniquet, nasal atomizer, ampoule) from the medicine bag. Time interval ends upon completed administration of analgesic.

    During simulation training (expected <5 minutes)

Secondary Outcomes (4)

  • Total time spent on scene (minutes)

    During simulation training (expected <10 minutes)

  • Time required for obtaining IV access

    During simulation training (expected <5 minutes)

  • Time required preparing IN administration

    During simulation training (expected <0.5 minute)

  • Satisfaction of the navy nurse regarding the used route of administration.

    Directly after completion of simulation training

Study Arms (2)

IV first

OTHER

Subjects in this group will be instructed to use intravenous administration in the first scenario and use intranasal administration in the second scenario.

Other: Intravenous administrationOther: Intranasal administration

IN first

OTHER

Subjects in this group will be instructed to use intranasal administration in the first scenario and use intravenous administration in the second scenario.

Other: Intravenous administrationOther: Intranasal administration

Interventions

Analgesia is administered intravenously.

IN firstIV first

Analgesia is administered intranasally using an atomizer.

IN firstIV first

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All navy healthcare personnel attending (simulation) training on prehospital trauma care.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Amsterdam UMC

Amsterdam, North Holland, 1105AZ, Netherlands

Location

MeSH Terms

Conditions

Agnosia

Interventions

Administration, IntravenousAdministration, Intranasal

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Drug Administration RoutesDrug TherapyTherapeuticsAdministration, MucosalAdministration, Topical

Study Officials

  • Markus W Hollmann, PhD

    Amsterdam UMC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 8, 2024

First Posted

April 8, 2024

Study Start

March 13, 2024

Primary Completion

September 10, 2024

Study Completion

September 10, 2024

Last Updated

January 29, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations